Death pathways associated with photodynamic therapy

Area of Science:

• Cell Biology
• Biochemistry
• Oncology

Background:

• Photodynamic therapy (PDT) is a treatment modality that utilizes photosensitizers and light to generate reactive oxygen species, leading to cell death.
• The specific cellular targets of PDT and their downstream effects on cell fate pathways, such as apoptosis and autophagy, are complex and not fully elucidated.

Purpose of the Study:

• To investigate the differential outcomes of photodynamic therapy (PDT) based on the subcellular localization of photosensitizer-induced photodamage.
• To elucidate the roles of apoptosis and autophagy in response to PDT-induced cellular damage.

Main Methods:

• Targeting of mitochondria, endoplasmic reticulum, lysosomes, or plasma membrane with photosensitizers followed by light activation.
• Analysis of protein photodamage, including anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bid.
• Assessment of apoptotic and autophagic pathway activation.
• Evaluation of apoptosis impairment and immune responses.

Main Results:

• Photodamage to mitochondria or endoplasmic reticulum led to Bcl-2 photodamage and subsequent apoptosis when the pathway was available.
• Lysosomal photodamage activated Bid, promoting apoptosis.
• Plasma membrane photodamage resulted in sensitizer migration and procaspase photodamage, impairing apoptosis.
• In the absence of functional apoptosis, cells underwent autophagy.
• Autophagy was observed concurrently with apoptosis in some PDT responses and may contribute to immune responses against photodamaged tumor cells.

Conclusions:

• The subcellular site of photodamage dictates the cell death pathway activated by PDT, predominantly apoptosis or autophagy.
• PDT-induced apoptosis can be modulated by the integrity of the apoptotic machinery and the specific photodamaged targets.
• Autophagy serves as an alternative cell death pathway when apoptosis is compromised and may play a role in anti-tumor immunity.